BA
The Boeing Company
BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
OTIS
Otis Worldwide Corporation
OTIS has the edge over BA overall, supported by stronger valuation and lower modeled downside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
OTIS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
OTIS's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over OTIS in the historical PE scenario, which offers more potential upside but is not a forecast.
OTIS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $77.14 | — |
| Current | 19x | $77.14 | — |
| Cheap | 23x | $94.13 | +22% |
| Fair | 27x | $107 | +39% |
| Expensive | 30x | $122 | +58% |
Historical ranges are pointers, not guarantees.
OTIS's PE is in its cheap range at 19x. If earnings grow as analysts expect, today's price would be 18x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
BA has the edge over OTIS on the outlook, with more favorable revenue expectations.
OTIS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect OTIS's earnings to grow and its profitability to improve, with its revenue holding steady.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
OTIS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.37 | +8.7% |
| Q3 2026 | $4.02 | +18% |
| Q2 2026 | $3.89 | +2.6% |
| Q1 2026 | $3.76 | -1.6% |
| Q4 2025 | $3.50 | -14% |
| Q3 2025 | $3.40 | -15% |
| Q2 2025 | $3.79 | +5.9% |
| Q1 2025 | $3.82 | +10% |
| Q4 2024 | $4.07 | +20% |
OTIS has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over OTIS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
OTIS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.9B | +6.1% |
| Q2 2026 | $3.9B | +7.3% |
| Q1 2026 | $3.6B | +6.4% |
| Q4 2025 | $3.8B | +3.3% |
| Q3 2025 | $3.7B | +4% |
| Q2 2025 | $3.6B | -0.2% |
| Q1 2025 | $3.4B | -2.5% |
| Q4 2024 | $3.7B | +1.5% |
OTIS's revenue has grown year over year for five quarters in a row: $3.9B last quarter, up 6.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | 0 points |
| Q2 2026 | 15% | -0.3 points |
| Q1 2026 | 15% | +2.8 points |
| Q4 2025 | 16% | +1.1 points |
| Q3 2025 | 16% | +5.7 points |
| Q2 2025 | 15% | -0.6 points |
| Q1 2025 | 12% | -3.6 points |
| Q4 2024 | 14% | 0 points |
OTIS has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over OTIS on cash flow, with more consistent year-over-year improvement.
OTIS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $298M | -12% |
| Q2 2026 | $223M | +25% |
| Q1 2026 | $380M | +144% |
| Q4 2025 | $772M | +19% |
| Q3 2025 | $337M | -6.9% |
| Q2 2025 | $179M | -37% |
| Q1 2025 | $156M | +11% |
| Q4 2024 | $651M | +17% |
OTIS's free cash flow has been positive every quarter for seven years: $1.7B over the past year, up 26% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
OTIS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -1.6M shares |
| 1 year | -2.8% | -10.9M shares |
| 3 years | -7.7% | -31.8M shares |
| 5 years | -11% | -48.7M shares |
| Available history | -12% | -51.2M shares |
OTIS has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $407M |
| Q1 2026 | $400M |
| Q4 2025 | — |
| Q3 2025 | $248M |
| Q2 2025 | $308M |
| Q1 2025 | $253M |
| Q4 2024 | $207M |
OTIS spent $807M buying back its own shares over the past year, down 21% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
OTIS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Moderate |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 3.0x | Moderate |
| Q3 2025 | 3.2x | Elevated |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.2x | Elevated |
| Q4 2024 | 2.8x | Moderate |
OTIS has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
OTIS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.8 | Neutral |
| Stochastic | 86.8 | Overbought |
OTIS's weekly RSI is 57 (neutral) and its Stochastic is 87 (overbought).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over OTIS on valuation relative to its sector.
OTIS PE vs Industrials Sector
| Metric | OTIS | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 24x | 20% below |
| PE % | 6 | 57 | 51 pts below |
OTIS is trading at 19x earnings, a 20% discount to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
OTIS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $71.8 | 7.5% above |
| 20 week MA | $71.8 | 7.4% above |
| 50 week MA | $77.9 | 1% below |
| 100 week MA | $86.0 | 10% below |
| 200 week MA | $88.1 | 12% below |
OTIS has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
OTIS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $45.0 | $65.8 | +46% |
| 2021 | $65.8 | $85.3 | +30% |
| 2022 | $85.3 | $78.4 | -8.1% |
| 2023 | $78.4 | $89.5 | +14% |
| 2024 | $89.5 | $93.5 | +4.5% |
| 2025 | $93.5 | $87.6 | -6.3% |
| 2026 YTD | $87.6 | $77.1 | -12% |
OTIS has the edge over BA on returns for 2026, with the stronger performance.